Related Experiment Video
Updated: Jun 9, 2026

A High-throughput, High-content, Liquid-based C. elegans Pathosystem
Published on: July 1, 2018
Identification of a family of species-selective complex I inhibitors as potential anthelmintics
Taylor Davie1,2, Xènia Serrat1,2, Lea Imhof3,4
1The Donnelly Centre, University of Toronto, 160 College Street, Toronto, M5S 3E1, Canada.
Abstract:
Soil-transmitted helminths (STHs) are major pathogens infecting over a billion people. There are few classes of anthelmintics and there is an urgent need for new drugs. Many STHs use an unusual form of anaerobic metabolism to survive the hypoxic conditions of the host gut. This requires rhodoquinone (RQ), a quinone electron carrier. RQ is not made or used by vertebrate hosts making it an excellent therapeutic target. Here we screen 480 structural families of natural products to find compounds that kill Caenorhabditis elegans specifically when they require RQ-dependent metabolism. We identify several classes of compounds including a family of species-selective inhibitors of mitochondrial respiratory complex I. These identified complex I inhibitors have a benzimidazole core and we determine key structural requirements for activity by screening 1,280 related compounds. Finally, we show several of these compounds kill adult STHs. We suggest these species-selective complex I inhibitors are potential anthelmintics.
Related Concept Videos
Enzyme Inhibition
Chemical Agents for Microbial Control
Biological Methods for Microbial Control
Production of Biopesticides
Inhibitors of Bacterial DNA Synthesis
Anthelminthic Agents

